This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks End Higher After Encouraging Economic Data


NEW YORK (TheStreet) -- Stocks closed up Thursday as data showed surprising resilience in German business confidence and further stabilization in U.S. jobless claims.

The Dow Jones Industrial Average was up 46.1 points, 0.4%, at 12,984.8 after sinking by about 56 points earlier in the session. The S&P 500 was up 5.8 points, or 0.4%, at 1363.5. The Nasdaq finished higher by 23.8 points, or 0.8%, at 2957.

As stocks rebounded, Michael Gayed, chief investment strategist at Pension Partners, advised to "watch small-cap stocks, which have weakened in the past two weeks. If outperformance [in the intraday] continues in high beta areas and leadership resumes, new highs could soon follow." The small-cap Russell 2000 Index was rising 1.2%, compared to the S&P's increase of 0.2%, a full percentage difference.

If high-beta, small cap stocks continue to outperform low-beta, large cap stocks, that is a sign that the market is "internally sensing" risk-taking despite the gains already made, says Gayed. "Perhaps more [gains] are still coming," he surmised.

The Labor Department reported that the number of Americans filing unemployment claims for the first time in the week ended Feb. 18 was unchanged from the previous week's revised figure of 351,000. Economists surveyed by Thomson Reuters expected a rise to 354,000 from an originally reported four-year low of 348,000.

The Labor Department added that the four-week moving average fell 7,000 to 359,000 from the previous week's revised average of 366,000.

The report also noted that the number of people continuing to collect jobless benefits fell 52,000 in to 3.39 million in the week ended Feb. 11, from 3.44 million the preceding week.

"Some of this decline may be due to the expiration of benefits rather than previously displaced workers finding new jobs," noted Millan Mulraine, senior U.S. strategist, TD Securities. "Nevertheless, at these levels claims are consistent with the U.S. economy generating at a 200,000 plus pace and as such we expect employment growth in February to fall within this range, suggesting that the labor market is continuing to build on the positive momentum generated over the past two months."

In other domestic economic news, the Federal Housing Finance Agency reported that home prices rose 0.7% on a seasonally-adjusted basis in December, after increasing a revised 0.7% in November. Previously it was reported that prices rose 1% in November.

A Thursday report pointed to the surprising resilience of business confidence in Germany, Europe's largest economy, despite economic fears in surrounding eurozone nations. The Munich-based Ifo institute said its business-climate index, based on a survey 7,000 executives, grew to 109.6 in February from 108.3 in January -- the fourth-straight increase and the strongest in seven months. The data topped expectations of a reading of 108.8 according to a survey of economists by Thomson Reuters and helped offset some of the overnight news saying that the European Commission now estimates that the eurozone will experience a "mild recession" in 2012, with its economy shrinking by 0.3% this year.

In Greece, lawmakers were reportedly getting ready to sign off on a debt swap with private creditors Thursday as a key part of the European Union and International Monetary Fund-backed €130 billion bailout, even as protests erupted over the steep budget cuts required by the deal. The swap, which requires private bondholders to replace their existing Greek debt holdings with ones of lower value, would reduce Greece's debt by €100 billion ($132 billion) and help slash the country's debt to 121% of its gross domestic product by 2020 from the 160% of GDP currently.

Germany's DAX finished down 0.5% while London's FTSE closed up 0.36% Thursday. Japan's Nikkei Average settled up 0.44% and Hong Kong's Hang Seng finished down 0.78%.

In corporate news,

Apple (AAPL) moved to give its shareholders a bigger say in appointing directors to the company's board. The tech giant said directors who cannot garner a majority vote from shareholders would voluntarily resign. The decision, made during Apple's shareholder meeting Thursday, comes days after the stock hit an all-time high of $526.29 apiece. The iPhone and iPad maker still needs to address what it plans to do with its cash pile of nearly $98 billion. Shares were up 0.7% to $516.39.

Hewlett-Packard (HPQ), the PC and printer maker, said first-quarter adjusted earnings topped analysts' estimates but its outlook for the current quarter came in short of Wall Street expectations. HP said it expects earnings of 88 cents to 91 cents per share for the quarter ending in April, below the average estimate of analysts polled by Thomson Reuters for a profit of 95 cents. Shares tumbled 6.5% to $27.05.

Sears (SHLD) lost big during the holiday season, with net losses at $2.4 billion in the fourth quarter. Profit in the same period a year ago was $373 million. Earnings per share plummeted to $0.54 cents from $3.67 a year earlier and revenue decreased to $12.48 billion from $13 billion a year earlier. Analysts forecast earnings of 78 cents a share in the fourth quarter on sales of $12.44 billion. Rumors have been circulating that owner Edward Lampert will take Sears, the struggling retail chain, private. Shares surged by 18.7% to $61.80.

Target (TGT) beat estimates for 2012 earnings, which the Minneapolis-based company expects at $4.55 to $4.75 a share. The second largest U.S. discount reported $1.49 a share in fourth-quarter profit on revenue of $21.3 billion. Analysts expected profit of $1.40 a share on revenue of $21.21 billion. The stock was up 2.9% to $54.50.

Vivus (VVUS) said Wednesday a Food and Drug Administration panel recommended the agency approve Qnexa, the company's proposed treatment for obesity in adults. The FDA will review the company's new drug application for Qnexa, which was submitted in October 2011. The recommendation from the FDA panel doesn't guarantee the drug will receive approval from the agency. Shares soared 77.5% to $18.73.

April oil futures rose $1.55 to $107.83 a barrel. In other commodities, April gold futures advanced $15 to $1,786.30 an ounce amid the dip in the dollar and expectations that central banks will facilitate loose monetary policies for the foreseeable future.

The dollar index was down 0.4% at $78.91. The benchmark 10-year Treasury was falling 6/32, raising the yield to 2.028%.

-- Written by Andrea Tse and Chao Deng in New York.



>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to http://twitter.com/atwtse .

>To submit a news tip, send an email to: tips@thestreet.com.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs